Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Jian-Ni Qi"'
Autor:
Li-yun Xu, Jian-ni Qi, Xiao Liu, Hong-xin Ma, Wei Yuan, Pei-qing Zhao, Xiao-hong Liang, Yong Xu, Hong-xing Wang, Xiao-yan Xu, Wei Wang, Chun-hong Ma, Li-fen Gao
Publikováno v:
PLoS ONE, Vol 10, Iss 4, p e0124771 (2015)
T cell immunoglobulin- and mucin-domain-containing molecule-4 (Tim-4) receives much attention as a potentially negative regulator of immune responses. However, its modulation on macrophages has not been fully elucidated so far. This study aimed to id
Externí odkaz:
https://doaj.org/article/86be7669baf14b6eb8ebfe6094db5d2d
Autor:
Yue Min Feng, Tian Tian Liu, Xiao Nan Su, Qiang Zhu, Cheng Yong Qin, Jian Ni Qi, Hao Wu, Xiao Yu Xie
Publikováno v:
Journal of Digestive Diseases. 21:650-663
Objectives We aimed to establish a novel prognostic long noncoding RNA (lncRNA) signature for hepatitis B virus-related hepatocellular carcinoma (HBV-HCC) patients after hepatectomy and to validate its prognostic efficacy compared with other clinical
Autor:
Chenxi Liu, Xiaowen Ma, Yuemin Feng, Hao Wu, Qiang Zhu, Jian-ni Qi, Xiaoyu Xie, Zhen Yu, Le Wang, Xiaonan Su
Publikováno v:
Cell Death Discovery, Vol 6, Iss 1, Pp 1-14 (2020)
Cell Death Discovery
Cell Death Discovery
Pathological angiogenesis is an important component of hepatic fibrosis along with fibrous deposition, but its role is not well understood. Here, we demonstrated that fibronectin containing extra domain A(FN-EDA), a fibronectin splice variant highly
Autor:
Xing Wang, Hao-ran Bu, Yuemin Feng, Le Wang, Qiang Zhu, Jian-ni Qi, Xiaoyu Xie, Xiaowen Ma, Hao Wu
Publikováno v:
Surgical Oncology. 26:236-241
Combination of transcatheter arterial chemoembolization (TACE) and radiofrequency ablation (RFA) has become an effective alternative therapy for hepatocellular carcinoma (HCC). In clinical practice, the choice of time interval between TACE and RFA is
TRIM31 enhances chemoresistance in glioblastoma through activation of the PI3K/Akt signaling pathway
Autor:
Bing‑Yu Liu, Zhi‑Ping Dun, Chengwei Wang, Xue‑Ying Zhao, Ming‑De Fan, Yang Jiang, Qi Pang, Rui Zhang, Jian‑Ni Qi
Publikováno v:
Experimental and Therapeutic Medicine
Temozolomide (TMZ) resistance is a complication of treatment of glioma, and new strategies are urgently required to overcome chemoresistance in glioma cells. In the present study, it was demonstrated that tripartite motif-containing 31 (TRIM31) was a
Autor:
Panpan Hao, Jian-Ni Qi, Ying Li, Bin Li, Wei Yi, Fu Wang, Yong Zhang, Guohai Su, Rui-Hong Yin, Qingzan Kong, Xiao-Jun Cai, Jie Xiao, Xiaoping Ji, Zhuo Zhao
Publikováno v:
Oncotarget
Proprotein convertase-subtilisin/kexin type 9 (PCSK9) monoclonal antibody is a new therapy to reduce low-density lipoprotein cholesterol (LDL-C) level in patients with familial hypercholesterolemia (FH). This pooled analysis aimed to estimate the eff
Autor:
Yue-min Feng1, Xing Wang2, Le Wang1, Xiao-wen Ma1, Hao Wu1, Hao-ran Bu1, Xiao-yu Xie1, Jian-ni Qi3, Qiang Zhu1 zhuqiang@medmail.com.cn
Publikováno v:
Surgical Oncology. Sep2017, Vol. 26 Issue 3, p236-241. 6p.